The historical rank and industry rank for Polarean Imaging's Days Payable or its related term are showing as below:
LSE:POLX'
s Days Payable Range Over the Past 10 Years
Min: 100.72 Med: 267.22 Max: 551.18
Current: 494.89
During the past 9 years, Polarean Imaging's highest Days Payable was 551.18. The lowest was 100.72. And the median was 267.22.
LSE:POLX's Days Payable is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 68.07
vs LSE:POLX: 494.89
Polarean Imaging's Days Payable
increased
from Jun. 2024 (502.09) to Jun. 2025 (1,033.27).
It may suggest that Polarean Imagingdelayed paying its suppliers.
Polarean Imaging Days Payable Related Terms
Polarean Imaging Days Payable Historical Data
* Premium members only.
The historical data trend for Polarean Imaging's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:POLX vs FOFA, BTCY, LFWD: Days Payable Comparison
For the Medical Devices subindustry, Polarean Imaging's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polarean Imaging Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Days Payable distribution charts can be found below:
* The bar in red indicates where Polarean Imaging's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Polarean Imaging's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polarean Imaging (LSE:POLX) has a Days Payable of 1,033.27 as of Jun. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Polarean Imaging and its competitors. This is 287% above median its historical median of 267.22. Over the past decade, Polarean Imaging's Days Payable has ranged from 100.72 to 551.18.
Is Polarean Imaging's Days Payable too high?
Polarean Imaging's current Days Payable of 1,033.27 is 287% above median its 10-year median of 267.22. Over the past 10 years, this metric has ranged from a low of 100.72 to a high of 551.18. The Medical Devices & Instruments industry median Days Payable is 68.07. Polarean Imaging's value of 1,033.27 is 1418% above this industry median.
How does Polarean Imaging's Days Payable compare to FOFA and BTCY?
Polarean Imaging's Days Payable of 1,033.27 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Payable is 68.07. Polarean Imaging's value of 1,033.27 is 1418% above this benchmark. Historically, Polarean Imaging's own Days Payable has ranged from 100.72 to 551.18 over the past decade. While the company's 10-year median is 267.22 vs. the industry median of 68.07, Polarean Imaging has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polarean Imaging's current Days Payable of 1,033.27 is 1418% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Polarean Imaging and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polarean Imaging's current Days Payable is 1,033.27, which is 287% above median its own 10-year median of 267.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (LSE:POLX) has a current Days Payable of 1,033.27. The current Days Payable is 1,033.27, which is 287% above median its 10-year median of 267.22 and 1418% above the Medical Devices & Instruments industry median of 68.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Polarean Imaging (LSE:POLX), the current Days Payable is 1,033.27 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:POLX has been successfully added to your 